Eugene David ...The One-Minute Pundit |
|
Saturday, January 22, 2005
It's a HERD! It's a PAIN! It's -- SUPER-ASPIRIN!!!!!
COX-2 inhibitors cost 10 to 15 times as much as the drugs they replaced, the study published in the Archives of Internal Medicine said. NOT OUR MONEY! Within a year of being introduced in 1999, Vioxx and Celebrex were being heavily promoted as "super-aspirin" and bringing in billions of dollars in revenue annually, the study said. Merck spent $161 million in 2000 on direct-to-consumer marketing of Vioxx, it said. That's a lot of junk television and INVESTIGATIVE REPORTS to pay for.
|